DuPont de Nemours, Inc. (NYSE:DD – Get Free Report) has been given an average rating of “Moderate Buy” by the sixteen research firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, three have assigned a hold recommendation and twelve have given a buy recommendation to the company. The average 12-month price objective among brokers that have covered the stock in the last year is $55.2143.
A number of research analysts recently issued reports on DD shares. Argus decreased their target price on shares of DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating for the company in a research report on Thursday, February 5th. Weiss Ratings upgraded shares of DuPont de Nemours from a “sell (d)” rating to a “sell (d+)” rating in a research report on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of DuPont de Nemours from $58.00 to $60.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Wolfe Research boosted their target price on shares of DuPont de Nemours from $49.00 to $54.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. Finally, Royal Bank Of Canada boosted their target price on shares of DuPont de Nemours from $56.00 to $60.00 and gave the company an “outperform” rating in a research report on Monday, May 11th.
Get Our Latest Report on DuPont de Nemours
Institutional Inflows and Outflows
DuPont de Nemours Trading Up 2.1%
NYSE DD opened at $48.15 on Friday. The company has a market capitalization of $19.74 billion, a PE ratio of -802.42, a P/E/G ratio of 1.36 and a beta of 1.02. The company has a fifty day moving average of $46.69 and a 200 day moving average of $44.46. DuPont de Nemours has a 1 year low of $27.16 and a 1 year high of $52.66. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.68 and a quick ratio of 2.11.
DuPont de Nemours (NYSE:DD – Get Free Report) last posted its earnings results on Tuesday, May 5th. The basic materials company reported $0.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.07. The company had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. DuPont de Nemours had a negative net margin of 0.30% and a positive return on equity of 7.15%. The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the firm posted $1.03 earnings per share. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. Research analysts forecast that DuPont de Nemours will post 2.39 earnings per share for the current year.
DuPont de Nemours Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Friday, May 15th will be given a dividend of $0.20 per share. The ex-dividend date is Friday, May 15th. This represents a $0.80 dividend on an annualized basis and a yield of 1.7%. DuPont de Nemours’s payout ratio is currently -1,333.33%.
About DuPont de Nemours
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
See Also
- Five stocks we like better than DuPont de Nemours
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
